155 related articles for article (PubMed ID: 9199747)
21. Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data.
Abad S; Monnet D; Caillat-Zucman S; Mrejen S; Blanche P; Chalumeau M; Mouthon L; Dhote R; Brézin AP
Ocul Immunol Inflamm; 2008; 16(1):3-8. PubMed ID: 18379934
[TBL] [Abstract][Full Text] [Related]
22. Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.
Hou S; Yang P; Du L; Zhou H; Lin X; Liu X; Kijlstra A
Mol Vis; 2008; 14():2597-603. PubMed ID: 19122825
[TBL] [Abstract][Full Text] [Related]
23. Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease.
Shindo Y; Ohno S; Yamamoto T; Nakamura S; Inoko H
Hum Immunol; 1994 Mar; 39(3):169-76. PubMed ID: 8026985
[TBL] [Abstract][Full Text] [Related]
24. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
[TBL] [Abstract][Full Text] [Related]
25. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome.
Zhang XY; Wang XM; Hu TS
Am J Ophthalmol; 1992 May; 113(5):567-72. PubMed ID: 1575232
[TBL] [Abstract][Full Text] [Related]
26. Vogt-Koyanagi-Harada disease and HLA type in Italian patients.
Pivetti-Pezzi P; Accorinti M; Colabelli-Gisoldi RA; Pirraglia MP
Am J Ophthalmol; 1996 Dec; 122(6):889-91. PubMed ID: 8956647
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the association of Vogt-Koyanagi-Harada syndrome with IL23R-C1orf141 in Han Chinese Singaporean and ADO-ZNF365-EGR2 in Thai.
Cao S; Chee SP; Yu HG; Sukavatcharin S; Wu L; Kijlstra A; Hou S; Yang P
Br J Ophthalmol; 2016 Mar; 100(3):436-42. PubMed ID: 26628628
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins.
Rutzen AR; Ortega-Larrocea G; Schwab IR; Rao NA
Am J Ophthalmol; 1995 Feb; 119(2):239-40. PubMed ID: 7832237
[TBL] [Abstract][Full Text] [Related]
29. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease.
Alaez C; del Pilar Mora M; Arellanes L; Cano S; Perez-Luque E; Vazquez MN; Olivo A; Burguete A; Hernandez A; Pedroza M; Gorodezky C
Hum Immunol; 1999 Sep; 60(9):875-82. PubMed ID: 10527396
[TBL] [Abstract][Full Text] [Related]
30.
Anukul N; Pathanapitoon K; Leetrakool N; Guntiya T; Wita R; Palacajornsuk P; Klangsinsirikul P
Ocul Immunol Inflamm; 2021 Feb; 29(2):260-263. PubMed ID: 32965138
[TBL] [Abstract][Full Text] [Related]
31. Correlation between visual acuity and human leukocyte antigen DRB1*04 in patients with Vogt-Koyanagi-Harada disease.
Misawa N; Tagami M; Kohno T; Honda S
BMC Ophthalmol; 2019 Nov; 19(1):214. PubMed ID: 31699055
[TBL] [Abstract][Full Text] [Related]
32. Application of revised diagnostic criteria for vogt-koyanagi-harada disease in Japanese patients.
Yamaki K; Hara K; Sakuragi S
Jpn J Ophthalmol; 2005; 49(2):143-8. PubMed ID: 15838732
[TBL] [Abstract][Full Text] [Related]
33. MIF gene polymorphisms confer susceptibility to Vogt-Koyanagi-Harada syndrome in a Han Chinese population.
Zhang C; Liu S; Hou S; Lei B; Zheng X; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7734-8. PubMed ID: 24194192
[TBL] [Abstract][Full Text] [Related]
34. Analysis of human leukocyte antigen HLA-DR beta amino acid sequence in Vogt-Koyanagi-Harada syndrome.
Numaga J; Matsuki K; Tokunaga K; Juji T; Mochizuki M
Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):1958-61. PubMed ID: 2055689
[TBL] [Abstract][Full Text] [Related]
35. JAK1, but not JAK2 and STAT3, confers susceptibility to Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population.
Hu K; Hou S; Li F; Xiang Q; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3360-5. PubMed ID: 23611997
[TBL] [Abstract][Full Text] [Related]
36. HLA-DRB1*04:05 is involved in the development of Vogt-Koyanagi-Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors.
Takeuchi M; Meguro A; Nakamura J; Chikagawa R; Osada R; Shibuya E; Hasumi Y; Yamada N; Ishihara M; Mizuki N
Sci Rep; 2023 Aug; 13(1):13580. PubMed ID: 37604934
[TBL] [Abstract][Full Text] [Related]
37. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
[TBL] [Abstract][Full Text] [Related]
38. [Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome].
Yang P; Wang H; Zhou H; Huang X; Zhong H; Chen L; Zhong H; Fu T
Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):736-9. PubMed ID: 12654224
[TBL] [Abstract][Full Text] [Related]
39. Vogt-Koyanagi-Harada syndrome in a Greenlandic Inuit.
Ostergaard J; Goldschmidt E; Andersen N
Acta Ophthalmol; 2008 Aug; 86(5):576-8. PubMed ID: 18039349
[TBL] [Abstract][Full Text] [Related]
40. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.
Levinson RD; See RF; Rajalingam R; Reed EF; Park MS; Rao NA; Holland GN
Hum Immunol; 2004 Dec; 65(12):1477-82. PubMed ID: 15603876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
